Jeong Han Kang Selected Research

Jeong Han Kang Research Topics

Disease

6	Neoplasms (Cancer) 05/2012 - 10/2006
2	Fatty Liver 01/2015 - 07/2011
2	Atherosclerosis 03/2009 - 02/2006
2	Osteosarcoma (Osteogenic Sarcoma) 09/2008 - 10/2006
1	Non-alcoholic Fatty Liver Disease 01/2017
1	Alcoholic Liver Diseases (Alcoholic Liver Disease) 01/2017
1	Inflammation (Inflammations) 01/2015
1	Alcoholic Fatty Liver 01/2015
1	Pancreatic Neoplasms (Pancreatic Cancer) 04/2014
1	Hepatocellular Carcinoma (Hepatoma) 05/2012
1	Obesity 07/2011
1	Hypoxia (Hypoxemia) 03/2011
1	Breast Neoplasms (Breast Cancer) 03/2009
1	Nervous System Diseases (Neurological Disorders) 05/2008
1	Seizures (Absence Seizure) 05/2008
1	Epilepsy (Aura) 05/2008
1	Diabetic Nephropathies (Diabetic Nephropathy) 02/2008
1	Neoplasm Metastasis (Metastasis) 05/2007
1	Hypertension (High Blood Pressure) 10/2006
1	Necrosis 06/2006
1	Meningioma (Meningiomas) 02/2006

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 01/2017 - 02/2006
2	Biomarkers (Surrogate Marker)IBA 01/2017 - 03/2009
2	ascochlorinIBA 05/2012 - 10/2006
2	ProteomeIBA 09/2008 - 10/2006
1	Vitamin D-Binding ProteinIBA 01/2017
1	Ornithine-Oxo-Acid Transaminase (Ornithine Aminotransferase)IBA 01/2017
1	Phosphatidylethanolamine Binding ProteinIBA 01/2017
1	Methionine (L-Methionine)FDA Link 01/2015
1	CurcuminIBA 01/2015
1	Choline (Choline Chloride)IBA 01/2015
1	Protein Isoforms (Isoforms)IBA 01/2015
1	Member 1 Group A Nuclear Receptor Subfamily 4IBA 04/2014
1	1,1- bis(3'- indolyl)- 1- (4- hydroxyphenyl)methaneIBA 04/2014
1	Orphan Nuclear ReceptorsIBA 04/2014
1	ThioredoxinsIBA 04/2014
1	4-O-carboxymethylascochlorinIBA 05/2012
1	Fatty Acids (Saturated Fatty Acids)IBA 07/2011
1	4-O-methylascochlorinIBA 03/2011
1	Adenosine Triphosphate (ATP)IBA 03/2011
1	Antineoplastic Agents (Antineoplastics)IBA 03/2011
1	Adenosine (Adenocard)FDA LinkGeneric 03/2011
1	AMP-Activated Protein KinasesIBA 03/2011
1	Chloroquine (Aralen)FDA LinkGeneric 07/2009
1	Bortezomib (Velcade)FDA Link 07/2009
1	Proteasome InhibitorsIBA 07/2009
1	Adenine PhosphoribosyltransferaseIBA 03/2009
1	purineIBA 03/2009
1	TropomyosinIBA 03/2009
1	ascofuranoneIBA 09/2008
1	Endothelial Protein C ReceptorIBA 09/2008
1	Anti-Bacterial Agents (Antibiotics)IBA 09/2008
1	Terpenes (Terpenoids)IBA 09/2008
1	N-pivaloylleucyl-gamma-aminobutyric acidIBA 05/2008
1	3-Mercaptopropionic Acid (3 Mercaptopropionic Acid)IBA 05/2008
1	gamma-Aminobutyric Acid (GABA)IBA 05/2008
1	Neurotransmitter Agents (Neurotransmitter)IBA 05/2008
1	BicucullineIBA 05/2008
1	Anticonvulsants (Antiepileptic Drugs)IBA 05/2008
1	Pentylenetetrazole (Metrazol)IBA 05/2008
1	Transcription Factors (Transcription Factor)IBA 02/2008
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 05/2007
1	Triglycerides (Triacylglycerol)IBA 10/2006
1	CholesterolIBA 10/2006
1	Protein Phosphatase 2 (Protein Phosphatase 2A)IBA 02/2006
1	Biological ProductsIBA 02/2006
1	AntigensIBA 02/2006
1	LDL Lipoproteins (beta Lipoproteins)IBA 02/2006
1	Threonine (L-Threonine)FDA Link 02/2006
1	VimentinIBA 02/2006
1	Serine (L-Serine)FDA Link 02/2006
1	oxidized low density lipoproteinIBA 02/2006

Therapy/Procedure

1	Hip Replacement Arthroplasty (Total Hip Replacement) 06/2006